Viking Therapeutics Inc. (VKTX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
34.86
0.81 (2.38%)
At close: Jan 23, 2025, 3:59 PM
35.25
1.12%
After-hours Jan 23, 2025, 07:49 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
PE Ratio | -20.44 | -10.72 | -6.58 | -11.34 | -22.39 | -19.96 | -5.13 | -1.31 | -0.93 | -1.58 | -235.76 | -26.7 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 5.04 | 4.97 | 1.76 | 1.67 | 2.08 | 1.48 | 7.83 | 2.41 | 2.48 | -1.56 | -137.59 | -0.11 |
P/FCF Ratio | -23.93 | -14.92 | -7.46 | -18.77 | -23.32 | -23.49 | -7.15 | -1.75 | -2.48 | -21.67 | -440.72 | -59.28 |
P/OCF Ratio | -23.93 | -14.92 | -7.46 | -18.77 | -23.32 | -23.49 | -7.15 | -1.75 | -2.48 | -21.67 | -440.72 | -59.28 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | n/a | 0.26 | 0.41 | 0.25 | -0.07 | -1.11 | -0.41 |
Quick Ratio | 19.19 | 7.61 | 23.98 | 21.12 | 41.83 | 66.40 | 2.52 | 2.16 | 7.69 | 0.03 | 1.41 | n/a |
Current Ratio | 19.19 | 7.61 | 23.98 | 21.12 | 41.83 | 66.40 | 2.52 | 2.16 | 7.69 | 0.03 | 1.41 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -1.15K | n/a | -3.09K | -402.47 | -223.88 | -64.75 | -14.87 | -7.65 | -12.21 | -37.33 | -4.12 | n/a |
Return on Equity (ROE) | -0.25 | -0.46 | -0.27 | -0.15 | -0.09 | -0.07 | -1.53 | -1.83 | -2.68 | 0.99 | 0.58 | 0.00 |
Return on Assets (ROA) | -0.23 | -0.4 | -0.26 | -0.14 | -0.09 | -0.07 | -0.93 | -1.01 | -1.52 | -7.19 | -0.81 | n/a |
Return on Capital (ROIC) | -0.29 | -0.48 | -0.28 | -0.17 | -0.12 | -0.09 | -1.42 | -1.72 | -0.89 | 1.21 | -1.91 | 0.01 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |